Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
33%
OVERLAP
BY WEIGHT
11
# OF OVERLAPPING
HOLDINGS
HRTS
43
HOLDINGS
26%
ALSO IN MEDX
MEDX
27
HOLDINGS
41%
ALSO IN HRTS
SECTOR DRIFT (HRTS minus MEDX)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HRTS |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 11.6% | 18.9% | 11.6% |
|
MERCK & CO. INC. | 4.1% | 4.1% | 4.1% |
|
JOHNSON & JOHNSON | 3.8% | 5.8% | 3.8% |
 |
ASTRAZENECA PLC | 3.5% | 4.6% | 3.5% |
|
ABBVIE INC | 2.6% | 9.3% | 2.6% |
HRTS Overweight Relative to MEDX
|
UNITEDHEALTH GROUP INC | 5.6% |
 |
NOVO NORDISK A/S-B | 5.5% |
|
THERMO FISHER SCIENTIFIC INC | 4.2% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | 3.9% |
|
REVOLUTION MEDICINES, INC. | 3.4% |
|
CYTOKINETICS INC | 3.3% |
|
NOVARTIS AG | 3.3% |
|
GILEAD SCIENCES INC | 3.2% |
|
DANAHER CORP | 2.9% |
|
ABBOTT LABORATORIES | 2.9% |
HRTS Underweight Relative to MEDX
|
ELI LILLY & CO | -7.3% |
|
NOVARTIS AG-ADR | -7.0% |
|
ABBVIE INC | -6.7% |
 |
ALKERMES PLC | -5.8% |
|
PFIZER INC | -3.1% |
|
BIOGEN IDEC INC | -3.1% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -2.8% |
|
BRISTOL-MYERS SQUIBB CO | -2.8% |
|
IONIS PHARMACEUTICALS, INC. | -2.7% |
|
CRISPR THERAPEUTICS AG | -2.4% |